FDA Orange Book · active-ingredient family
Aspirin; omeprazole
Aspirin; omeprazole is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:YOSPRALA · NDA 205103
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, delayed release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| YOSPRALARLD×2 | GENUS LIFESCIENCES | NDA 205103 | — | Sep 14, 2016 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9987231 | Jan 02, 2033 | in 6 yr 8 mo | U-2324 |
| 9539214 | Mar 13, 2033 | in 6 yr 10 mo | U-1902 |
Aspirin; omeprazole — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
